# Case report: Non-linear evolution of oxytocin informs YBOCS changes post-DBS of the bed nucleus of the stria terminalis for treatment resistant OCD

**Authors:** Jean-Baptiste Belge, Vincent Geenen, Anne L. Salado, Bruno Kaschten, Didier Martin, Gabrielle Scantamburlo

PMC · DOI: 10.3389/fpsyt.2024.1473797 · Frontiers in Psychiatry · 2025-01-27

## TL;DR

This case study shows that oxytocin levels change in a non-linear way after brain stimulation for OCD, and these changes correlate with symptom severity.

## Contribution

The study reveals a novel non-linear relationship between oxytocin levels and OCD symptoms following BNST-DBS.

## Key findings

- Oxytocin levels showed a significant quadratic, non-linear trend over time.
- Changes in oxytocin levels were strongly correlated with OCD symptom severity as measured by YBOCS.
- The findings suggest oxytocin could be a potential biomarker for DBS treatment efficacy.

## Abstract

Obsessive-compulsive disorder (OCD) is a challenging neuropsychiatric condition with a subset of patients remaining refractory to conventional treatments. Deep brain stimulation (DBS) of the bed nucleus of the stria terminalis (BNST) has shown promise for severe, treatment-resistant OCD. This case report examines the relationship between plasma oxytocin levels and OCD symptom severity following BNST-DBS.

A 36-year-old patient with long-standing, treatment-resistant OCD underwent stereotactic implantation of DBS electrodes at the BNST. Postoperative assessments included OCD symptom severity using the Yale-Brown Obsessive Compulsive Scale (YBOCS) and plasma oxytocin levels, measured at 12 time points over three years. Longitudinal and correlational analyses were performed using linear and polynomial regression models.

Non-linear trends in oxytocin levels were identified, with polynomial regression revealing a significant quadratic term, suggesting a parabolic trend. Strong positive correlations were found between changes in oxytocin levels and YBOCS total, obsession, and compulsion scores.

The findings suggest a significant non-linear evolution of oxytocin levels and a positive correlation with OCD symptom changes following BNST-DBS. Oxytocin levels could serve as a biomarker for DBS efficacy if this finding is replicated in larger studies.

## Linked entities

- **Proteins:** OXT (oxytocin/neurophysin I prepropeptide)
- **Diseases:** obsessive-compulsive disorder (MONDO:0008114), OCD (MONDO:0001158)

## Full-text entities

- **Genes:** OXT (oxytocin/neurophysin I prepropeptide) [NCBI Gene 5020] {aka OT, OT-NPI, OXT-NPI}
- **Diseases:** OCD (MESH:D009771), neuropsychiatric condition (MESH:D001523), compulsion (MESH:D000073932)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11807955/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11807955/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC11807955/full.md

---
Source: https://tomesphere.com/paper/PMC11807955